Darius Matthews 57AB : You’re misquoting the Bible. Money is good and useful. It says the “love” of money is the root of all evil, not the money itself. So it’s the lust in us that is evil, not the money. Amen?

Darius Matthews : I got a lot of hate for saying ignore the cheerleaders in here.  Split was so obvious. Dilution again is next. Again so obvious

Darius Matthews EZ_money : Lol. Knew it would reverse split. That’s typically what happens when they get a delisting notice from Nasdaq which Lucy got end of last year. It was just a matter of time. Don’t need a crystal ball to know these things.

Darius Matthews EZ_money :

Darius Matthews EZ_money : Ik. It’s expected. Just was saying that’s why I’m not buying just yet. Like I told you before, for me to buy in they need to be a bit closer to profitability, not cash burning, and not having to do massive dilutions. I hate losing money.

Darius Matthews J1959 : So true

Darius Matthews : It’s a Trump pump. Nothing to do with rate cuts

Darius Matthews : Cool. Know that they could still issue more shares due to the convertible bonds left outstanding. Also they could RS if the Acquisition doesn’t happen. Just be aware and careful. Personally, I’m long about 50 percent, staying somewhat liquid for any big dips. Happy investing

Darius Matthews OP wwwarrior : Difference is this company has multiple acquisition offers on the table. This is a long for me. I would not day trade this because there’s lower float stocks out there for that. You’ll get more of a pump somewhere else.

Darius Matthews OP wwwarrior : There’s imo just one thing to watch out for with Renalytix. They could potential issue more shares to raise capital if their sales don’t tick up fast. But with this new collaboration that may not happen. This stock has major potential, and I mean major.